【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market share analysis, 2018
3.4. Porters five forces analysis
3.5. Clinical trials
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increase in prevalence of cancer
3.6.1.2. Surge in cancer research
3.6.1.3. Rise in strategic acquisitions & collaborations
3.6.2. Restraints
3.6.2.1. High cost of drug development and threat of failure
3.6.2.2. Adverse effects associated with cancer drug therapy
3.6.3. Opportunities
3.6.3.1. High potential associated with personalized medicines
3.6.3.2. Increase in purchasing power of emerging economies
CHAPTER 4: CANCER THERAPEUTICS MARKET, APPLICATION
4.1. Overview
4.1.1. Market size and forecast
4.2. Blood cancer
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Lung cancer
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Breast cancer
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Colorectal cancer
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Prostate cancer
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
4.7. Cervical cancer
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market analysis, by country
4.8. Head & neck cancer
4.8.1. Key market trends, growth factors, and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market analysis, by country
4.9. Glioblastoma
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region
4.9.3. Market analysis, by country
4.10. Malignant meningioma
4.10.1. Key market trends, growth factors, and opportunities
4.10.2. Market size and forecast, by region
4.10.3. Market analysis, by country
4.11. Mesothelioma
4.11.1. Key market trends, growth factors, and opportunities
4.11.2. Market size and forecast, by region
4.11.3. Market analysis, by country
4.12. Melanoma
4.12.1. Key market trends, growth factors, and opportunities
4.12.2. Market size and forecast, by region
4.12.3. Market analysis, by country
4.13. Others
4.13.1. Key market trends, growth factors, and opportunities
4.13.2. Market size and forecast, by region
4.13.3. Market analysis, by country
CHAPTER 5: CANCER THERAPEUTICS MARKET, BY TOP SELLING DRUGS
5.1. Overview
5.1.1. Market size and forecast
5.2. Revlimid
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by region
5.3. Avastin
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by region
5.4. Herceptin
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by region
5.5. Rituxan
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by region
5.6. Opdivo
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by region
5.7. Gleevec
5.7.1. Market size and forecast, by region
5.7.2. Market analysis, by region
5.8. Velcade
5.8.1. Market size and forecast, by region
5.8.2. Market analysis, by region
5.9. Imbruvica
5.9.1. Market size and forecast, by region
5.9.2. Market analysis, by region
5.10. Ibrance
5.10.1. Market size and forecast, by region
5.10.2. Market analysis, by region
5.11. Zytiga
5.11.1. Market size and forecast, by region
5.11.2. Market analysis, by region
5.12. Alimta
5.12.1. Market size and forecast, by region
5.12.2. Market analysis, by region
5.13. Xtandi
5.13.1. Market size and forecast, by region
5.13.2. Market analysis, by region
5.14. Tarceva
5.14.1. Market size and forecast, by region
5.14.2. Market analysis, by region
5.15. Perjeta
5.15.1. Market size and forecast, by region
5.15.2. Market analysis, by region
5.16. Temodar
5.16.1. Market size and forecast, by region
5.16.2. Market analysis, by region
5.17. Other drugs
5.17.1. Market size and forecast, by region
5.17.2. Market analysis, by region
CHAPTER 6: CANCER THERAPEUTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. North America market size and forecast, by country
6.2.2.1. U.S.
6.2.2.1.1. U.S. market size and forecast, by application
6.2.2.2. Canada
6.2.2.2.1. Canada market size and forecast, by application
6.2.3. North America market size and forecast, by application
6.2.4. North America market size and forecast, by top selling drugs
6.3. Europe
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Europe cancer therapeutics market, by country
6.3.2.1. Germany
6.3.2.1.1. Germany market size and forecast, by application
6.3.2.2. France
6.3.2.2.1. France market size and forecast, by application
6.3.2.3. UK
6.3.2.3.1. UK market size and forecast, by application
6.3.2.4. Italy
6.3.2.4.1. Italy market size and forecast, by application
6.3.2.5. Spain
6.3.2.5.1. Spain market size and forecast, by application
6.3.2.6. Rest of Europe
6.3.2.6.1. Rest of Europe market size and forecast, by application
6.3.3. Europe market size and forecast, by application
6.3.4. Europe market size and forecast, by top selling drugs
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Asia-Pacific market size and forecast, by country
6.4.2.1. Japan
6.4.2.1.1. Japan market size and forecast, by application
6.4.2.2. China
6.4.2.2.1. China market size and forecast, by application
6.4.2.3. India
6.4.2.3.1. India market size and forecast, by application
6.4.2.4. Taiwan
6.4.2.4.1. Taiwan market size and forecast, by application
6.4.2.5. South Korea
6.4.2.5.1. South Korea market size and forecast, by application
6.4.2.6. Australia
6.4.2.6.1. Australia market size and forecast, by application
6.4.2.7. Rest of Asia-Pacific
6.4.2.7.1. Rest of Asia-Pacific market size and forecast, by application
6.4.3. Asia-Pacific market size and forecast, by application
6.4.4. Asia-Pacific market size and forecast, by top selling drugs
6.5. LAMEA
6.5.1. Key market trends, growth factors, and opportunities
6.5.2. LAMEA market size and forecast, by country
6.5.2.1. Latin America
6.5.2.1.1. Latin America market size and forecast, by application
6.5.2.2. Middle East
6.5.2.2.1. Middle East market size and forecast, by application
6.5.2.3. Africa
6.5.2.3.1. Africa market size and forecast, by application
6.5.3. LAMEA market size and forecast, by application
6.5.4. LAMEA market size and forecast, by top selling drugs
CHAPTER 7: COMPANY PROFILES
7.1. AbbVie Inc.
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. Astellas Pharma Inc.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Bristol Myers Squibb Company
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. Celgene Corporation
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Eli Lilly and Company
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. F. Hoffmann-La Roche Ltd.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. EleInformatiBusiness performance
7.6.6. Key strategic moves and developments
7.7. Johnson & Johnson
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Merck & Co., Inc.
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Novartis AG
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Pfizer Inc.
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
【レポート販売概要】
■ タイトル：がん治療法の世界市場：用途別、人気商品別■ 英文：Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年7月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9NV072
■ 調査対象地域：グローバル
- 中国のバイオ燃料市場：バイオエタノール、バイオディーゼル、バイオジェット燃料About biofuels market in China The continuous growth in the population has led to increased power consumption in the production and transportation sectors. As a result, there is a rise in the level of pollution and GHG. China accounted for 23% of the global energy consumption in the year 2014 according to BP. Over-dependence on coal and oil for power generation and volatile oil prices have increas …
- 海水淡水化の世界市場2018-2022About Desalination Desalination is the process that is used to separate salts and other mineral salts from different types of water including seawater, brackish water, wastewater, and industrial water. The main types of technology involved in desalination process are thermal technology and membrane technology. Technavio’s analysts forecast the global desalination market to grow at a CAGR of 8.62% …
- Range Resources Corporation：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Range Resources Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an esse …
- オマーンの石油・ガス産業における中流（Midstream）市場展望Oman Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing Summary "Oman Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing" is a comprehensive report on midstream oil and gas industry in Oman. The report provides oil product …
- 医療機器受託製造の世界市場The global medical device contract manufacturing market was valued at $70bn in 2017. Visiongain forecasts this market to increase to $115bn in 2022. The market will grow at a CAGR of 9.5% throughout the forecast period. How this report will benefit you Read on to discover how you can exploit the future business opportunities emerging in this sector. In this brand new report you find 257-page repor …
- フランスの患者診察機器市場見通し（～2021）France Patient Examination Devices Market Outlook to 2021 Summary GlobalData’s new report, "France Patient Examination Devices Market Outlook to 2021", provides key market data on the France Patient Examination Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Stethoscopes and Thermometers. The r …
- アルミニウムダイカスト機械の世界市場：HPDC、LPDC、その他Global Aluminum Die Casting Machinery Market: About this market Technavio’s aluminum die casting machinery market analysis considers sales from HPDC, LPDC, and others. Our analysis also considers the sales of aluminum die casting machinery in APAC, Europe, MEA, North America, and South America. In 2018, the HPDC segment had a significant market share, and this trend is expected to continue over th …
- トラック隊列走行（プラトーニング）の世界市場予測（～2030年）“The rising number of road accidents due to driver error and increasing focus on reducing transportation operating cost will fuel the demand for the truck platooning market”The truck platooning market is projected to grow at a CAGR of 60.96% during the forecast period, and the market size is projected to grow from USD 37.6 million in 2021 to USD 2,728.7 million by 2030. The development of autonomo …
- ハードウェア暗号化の世界市場予測（～2022）：アルゴリズム＆標準別、アーキテクチャ別、製品別（内蔵・外付けハードディスクドライブ、ソリッドステートドライブ、USB、インライン暗号化装置）、用途別、産業別、地域別The hardware encryption market is expected to be valued at USD 413.85 Billion by 2022, at a CAGR of 29.3% between 2016 and 2022. The major factors driving the growth of the hardware encryption market include increasing concern for data security issue and privacy of data, growing requirement of regulatory compliances, expansion of digital content, and significant advantage over software encryption …
- 冷蔵・冷凍輸送サービスの世界市場2015-2019About Refrigerated Road Transportation Refrigerated road transportation is a logistics process that involves the transportation of temperature-sensitive perishable goods by means of road. It is an integrated component of cold chain logistics and also helps in the management and control of the flow of the cold chain supply process. Growing international trade has increased the need for the transpor …
- 世界の銅産業動向The global copper industry expanded by over 40% in 2011 and accounted for $90 billion in revenues. The copper industry was greatly affected by a global drop in commodity prices in 2009, which caused a sharp decline in many markets. However, the decline was promptly reversed by increased consumption especially by fast developing countries like China. The mining of copper is generally confined to a …
- 世界のモバイル・ホットスポット・ルーター市場動向（2012-2016）TechNavio's analysts forecast the Global Mobile Hotspot Router market to grow at a CAGR of 34.16 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for optimum utilization of network capabilities. The Global Mobile Hotspot Router market has also been witnessing emergence of 3G and 4G hotspot routers. However, the high cost of 3G and 4G enabled …
- セザリー症候群(Sezary Syndrome)：世界の治験レビュー（2015年上半期版）Sezary Syndrome Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Sezary Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Sezary Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sezary Syndrome. It includes an overview of the trial numbers and their recruitment status as …
- マイクロアレイ解析の世界市場予測（～2023年）“The global microarray analysis market projected to grow at a CAGR of 7.6% during the forecast period.”The microarray analysis market is expected to reach USD 5.52 billion by 2023 from USD 3.82 billion in 2018, at a CAGR of 7.6%. The major factors driving the growth of this market are the growing application areas of microarrays, increasing incidence of cancer, and increasing funding for genomic a …
- ベーカーミキサーの世界市場2017-2021：スパイラルミキサー、プラネタリーミキサーAbout Baker Mixer Baker mixers are among the most useful and versatile pieces of equipment in commercial kitchens. Top vendors in the market are providing innovative features and attachments, which include bowl guards and belt drive system. Top vendors in the market are trying to provide baker mixers with different capacities to cater to the needs of different end-users. For instance, pizza shops …
